Elixiron Immunotherapeutics
PublicElixiron Immunotherapeutics is now publicly traded
The data on this page reflects Elixiron Immunotherapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series B
Jun 12, 2025
Total Funding Raised
$70M
Company Overview
Elixiron Immunotherapeutics is a clinical-stage biotechnology company that develops precision immunotherapies for neuroinflammatory diseases, autoimmune diseases, and cancer.
AI Layer
Application
Keywords
Elixiron Immunotherapeutics Comparables
Compare Elixiron Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pilatus Biosciences | 73% | |
| SynOx Therapeutics | 57% |
Elixiron Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 12, 2025 | ||||
| Grant | Jul 12, 2022 | ||||
| Series A Extension | Aug 23, 2021 | ||||
| Grant | Aug 25, 2020 | ||||
| Series A | Jul 31, 2019 |
Key People
Founding team and executive leadership
Elixiron Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A, Series A Extension |
| Fubon Financial Holding Venture Capital | Series A Extension |
| CDIB Capital International | Series A |
| China Investment & Development Company, Limited | Series A Extension |
| Alzheimer's Association | Grant |
| Fubon Financial Holdings | Series A Extension |
Recent news
Latest coverage and updates
- attends_eventJul 14, 2026
Elixiron Immunotherapeutics, Inc. attended event BIO Asia-Taiwan 2026 Special Forum on Jul 14th '26.
- attends_eventJul 13, 2026
Elixiron Immunotherapeutics, Inc. attended event Investment Summit on Jul 10th '26.
Elixiron Immunotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access